Have you used oral carbapenems to treat an outpatient with a complicated UTI caused by an ESBL-producing organism who would otherwise require hospitalization for IV carbapenem therapy, given concerns about community carbapenem stewardship?

1 Answers

Mednet Member

Infectious Disease · Zucker School of Medicine at Hofstra / Northwell

To date, the only oral carbapenem that is licensed in the U.S. is tebipenem. I have no experience with this drug and would be very interested in using it when it becomes readily available.